{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:25:36Z","timestamp":1789381536499,"version":"build-2803163510"},"reference-count":81,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The outbreak of monkeypox, coupled with the onslaught of the COVID-19 pandemic is a critical communicable disease. This study aimed to systematically identify and review research done on preclinical studies focusing on the potential monkeypox treatment and immunization. The presented juxtaposition of efficacy of potential treatments and vaccination that had been tested in preclinical trials could serve as a useful primer of monkeypox virus. The literature identified using key terms such as monkeypox virus or management or vaccine stringed using Boolean operators was systematically reviewed. Pubmed, SCOPUS, Cochrane, and preprint databases were used, and screening was performed in accordance with PRISMA guidelines. A total of 467 results from registered databases and 116 from grey literature databases were screened. Of these results, 72 studies from registered databases and three grey literature studies underwent full-text screening for eligibility. In this systematic review, a total of 27 articles were eligible according to the inclusion criteria and were used. Tecovirimat, known as TPOXX or ST-246, is an antiviral drug indicated for smallpox infection whereas brincidofovir inhibits the viral DNA polymerase after incorporation into viral DNA. The ability of tecovirimat in providing protection to poxvirus-challenged animals from death had been demonstrated in a number of animal studies. Non-inferior with regard to immunogenicity was reported for the live smallpox\/monkeypox vaccine compared with a single dose of a licensed live smallpox vaccine. The trial involving the live vaccine showed a geometric mean titre of vaccinia-neutralizing antibodies post two weeks of the second dose of the live smallpox\/monkeypox vaccine. Of note, up to the third generation of smallpox vaccines\u2014particularly JYNNEOS and Lc16m8\u2014have been developed as preventive measures for MPXV infection and these vaccines had been demonstrated to have improved safety compared to the earlier generations.<\/jats:p>","DOI":"10.3390\/v14112496","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:34:58Z","timestamp":1668393298000},"page":"2496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies"],"prefix":"10.3390","volume":"14","author":[{"given":"Nurizzati","family":"Sudarmaji","sequence":"first","affiliation":[{"name":"PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-7956","authenticated-orcid":false,"given":"Nurolaini","family":"Kifli","sequence":"additional","affiliation":[{"name":"PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9716-3126","authenticated-orcid":false,"given":"Andi","family":"Hermansyah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siang Fei","family":"Yeoh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National University Hospital, Singapore 119074, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1006-3649","authenticated-orcid":false,"given":"Bey-Hing","family":"Goh","sequence":"additional","affiliation":[{"name":"Biofunctional Molecule Exploratory Research Group (BMEX), School of Pharmacy, Monash University Malaysia, Bandar Sunway 47500, Malaysia"},{"name":"College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-1383","authenticated-orcid":false,"given":"Long Chiau","family":"Ming","sequence":"additional","affiliation":[{"name":"PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei"},{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"ref_1","unstructured":"Moore, M., and Zahra, F. (2022, July 24). Monkeypox, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK574519\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3201\/eid2002.130118","article-title":"Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo","volume":"20","author":"Kugelman","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alakunle, E., Moens, U., Nchinda, G., and Okeke, M.I. (2020). Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses, 12.","DOI":"10.3390\/v12111257"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: Clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"key":"ref_6","unstructured":"World Health Organization (WHO) (2022, July 24). Monkeypox: What You Need to Know. Available online: https:\/\/www.who.int\/multi-media\/details\/monkeypox--what-you-need-to-know?gclid=Cj0KCQjw2_OWBhDqARIsAAUNTTE0TModmdBO6QgSCjhMvugBad0K_mlmC3NmymgH9bF79gISnAguNxQaApUeEALw_wcB."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hutson, C.L., Carroll, D.S., Gallardo-Romero, N., Drew, C., Zaki, S.R., Nagy, T., Hughes, C., Olson, V.A., Sanders, J., and Patel, N. (2015). Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study Design. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/965710"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in cynomolgus monkeys","volume":"46","author":"Magnus","year":"1959","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"ref_9","first-page":"593","article-title":"A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bunge, E.M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L.R., and Steffen, R. (2022). The changing epidemiology of human monkeypox\u2014A potential threat? A systematic review. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010141"},{"key":"ref_11","unstructured":"Centers for Disease Control and Prevention (CDC) (2003). Multistate outbreak of monkeypox\u2014Illinois, Indiana, and Wisconsin. Morb. Mortal. Wkly. Rep., 23, 537\u2013540."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3201\/eid2505.190076","article-title":"Diagnosis of imported monkeypox, Israel, 2018","volume":"25","author":"Erez","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3201\/eid2608.191387","article-title":"Imported Monkeypox, Singapore","volume":"26","author":"Yong","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","unstructured":"World Health Organization (2022, October 27). Monkeypox Outbreak: Global Trends. Available online: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/infdis\/jiy326","article-title":"Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques","volume":"218","author":"Russo","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the Treatment of Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1128\/AAC.00208-15","article-title":"Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection","volume":"59","author":"Berhanu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with Monkeypox virus","volume":"85","author":"Smith","year":"2011","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/AAC.01044-08","article-title":"In vitro efficacy of ST246 against smallpox and monkeypox","volume":"53","author":"Smith","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: Determination of the minimal effective dose and human dose justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"Huggins","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2007.76.768","article-title":"Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection","volume":"76","author":"Sbrana","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00927-20","DOI":"10.1128\/mSphere.00927-20","article-title":"Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105179","DOI":"10.1016\/j.antiviral.2021.105179","article-title":"A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge","volume":"195","author":"Parker","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Shannon Keckler, M., Salzer, J.S., Patel, N., Townsend, M.B., Akazawa, Y.J., Doty, J.B., Gallardo-Romero, N.F., Satheshkumar, P.S., Carroll, D.S., and Karem, K.L. (2020). Imvamune\u00ae and acam2000\u00ae provide different protection against disease when administered postexposure in an intranasal monkeypox challenge prairie dog model. Vaccines, 8.","DOI":"10.3390\/vaccines8030396"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7883\/yoken.JJID.2016.417","article-title":"A single vaccination of nonhuman primates with highly attenuated smallpox vaccine, LC16m8, provides long-term protection against monkeypox","volume":"70","author":"Iizuka","year":"2017","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Franceschi, V., Parker, S., Jacca, S., Crump, R.W., Doronin, K., Hembrador, E., Pompilio, D., Tebaldi, G., Estep, R.D., and Wong, S.W. (2015). BoHV-4-based vector single heterologous antigen delivery protects STAT1(\u2212\/\u2212) mice from monkeypoxvirus lethal challenge. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003850"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.03481-12","article-title":"Assessment of the protective effect of imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques","volume":"87","author":"Hatch","year":"2013","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1016\/j.vaccine.2010.08.008","article-title":"Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys","volume":"28","author":"Zielinski","year":"2010","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2007.10.063","article-title":"Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge","volume":"26","author":"Marriott","year":"2008","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2007.02.041","article-title":"Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate","volume":"366","author":"Earl","year":"2007","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"Saijo","year":"2006","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/JVI.00984-08","article-title":"Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox","volume":"83","author":"Wei","year":"2009","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mucker, E.M., Wollen-Roberts, S.E., Kimmel, A., Shamblin, J., Sampey, D., and Hooper, J.W. (2018). Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006581"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-9-5","article-title":"In vitro inhibition of monkeypox virus production and spread by Interferon-\u03b2","volume":"9","author":"Johnston","year":"2012","journal-title":"Virol. J."},{"key":"ref_42","unstructured":"(2022, August 17). FDA Approves First Smallpox-Indicated Treatment, SIGA\u2019s TPOXX. Available online: https:\/\/www.genengnews.com\/topics\/drug-discovery\/fda-approves-first-smallpox-indicated-treatment-sigas-tpoxx\/."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fvl.11.27","article-title":"Development of the small-molecule antiviral ST-246 as a smallpox therapeutic","volume":"6","author":"Grosenbach","year":"2011","journal-title":"Future Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)","volume":"57","author":"Mucker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","unstructured":"(2022). Product Information: TPOXX(R) Oral Capsules, Intravenous Injection, Tecovirimat Oral Capsules, Intravenous Injection, SIGA Technologies Inc. (per FDA)."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3390\/v2122740","article-title":"Development of CMX001 for the Treatment of Poxvirus Infections","volume":"2","author":"Lanier","year":"2010","journal-title":"Viruses"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.antiviral.2006.10.009","article-title":"Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice","volume":"73","author":"Hostetler","year":"2007","journal-title":"Antivir. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","article-title":"Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies","volume":"38","author":"Tippin","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"ref_49","unstructured":"(2022, September 10). PubChem Compound Summary for CID 483477, Brincidofovir, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Brincidofovir."},{"key":"ref_50","unstructured":"FDA (2021). Approved Drug Products: Tembexa (brincidofovir) for oral administration, Chimerix."},{"key":"ref_51","unstructured":"World Health Organization (WHO) (2022, July 24). Monkeypox\u2014Questions and Answers. Available online: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/monkeypox?gclid=Cj0KCQjw2_OWBhDqARIsAAUNTTFk-3U7VjavJRwwI2eABaaTb1ggEnO_Uaqln6Cpb1KYSonkU3DyBaEaAm7WEALw_wcB."},{"key":"ref_52","unstructured":"National Institute of Allergy and Infectious Diseases (NIH) (2022, July 24). Monkeypox Treatment, Available online: https:\/\/www.niaid.nih.gov\/diseases-conditions\/monkeypox-treatment."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Foster, S.A., Parker, S., and Lanier, R. (2017). The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak. Viruses, 9.","DOI":"10.3390\/v9110320"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1128\/AAC.02814-14","article-title":"In vitro efficacy of brincidofovir against variola virus","volume":"58","author":"Olson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/v3010047","article-title":"Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans","volume":"3","author":"Rice","year":"2011","journal-title":"Viruses"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0147-9571(03)00025-0","article-title":"Smallpox vaccination and bioterrorism with pox viruses","volume":"26","author":"Mayr","year":"2003","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1086\/374244","article-title":"Progressive vaccinia","volume":"36","author":"Bray","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_58","first-page":"Cd004913","article-title":"Vaccines for preventing smallpox","volume":"2007","author":"Metzger","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2021.08.041","article-title":"Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members","volume":"39","author":"Decker","year":"2021","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: A newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_61","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"Eff. Clin. Pract."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: Modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1099\/0022-1317-68-10-2705","article-title":"Genetic analysis of vaccinia virus Lister strain and its attenuated mutant LC16m8: Production of intermediate variants by homologous recombination","volume":"68","author":"Suzuki","year":"1987","journal-title":"J. Gen. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7883\/yoken.JJID.2008.140","article-title":"Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: Differentiation of Congo Basin and West African MPXV strains","volume":"61","author":"Saijo","year":"2008","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"Randall","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.3390\/v2122763","article-title":"Monkeypox Virus Infections in Small Animal Models for Evaluation of Anti-Poxvirus Agents","volume":"2","author":"Hutson","year":"2010","journal-title":"Viruses"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: A review of preclinical and clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0300985810378649","article-title":"Animal models of orthopoxvirus infection","volume":"47","author":"Chapman","year":"2010","journal-title":"Vet. Pathol."},{"key":"ref_70","first-page":"377","article-title":"Studies on a pox disease of monkeys. I. Pathology","volume":"21","author":"Sauer","year":"1960","journal-title":"Am. J. Vet. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1099\/vir.0.005108-0","article-title":"A prairie dog animal model of systemic orthopoxvirus disease using west African and Congo Basin strains of Monkeypox virus","volume":"90","author":"Hutson","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3201\/eid1009.040310","article-title":"Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus","volume":"10","author":"Tesh","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3201\/eid1104.040907","article-title":"Experimental infection of prairie dogs with monkeypox virus","volume":"11","author":"Xiao","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus","volume":"84","author":"Stabenow","year":"2010","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Osorio, J.E., Iams, K.P., Meteyer, C.U., and Rocke, T.E. (2009). Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006592"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: Monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Hutson, C.L., Abel, J.A., Carroll, D.S., Olson, V.A., Braden, Z.H., Hughes, C.M., Dillon, M., Hopkins, C., Karem, K.L., and Damon, I.K. (2010). Comparison of West African and Congo Basin monkeypox viruses in BALB\/c and C57BL\/6 mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008912"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir Activity against Poxvirus Infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antivir. Res."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/11\/2496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:14:25Z","timestamp":1760145265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/11\/2496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":81,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["v14112496"],"URL":"https:\/\/doi.org\/10.3390\/v14112496","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}